Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases
Abstract
Research Article14 October 2016Open Access Transparent process Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases Jörg T Regula Jörg T Regula Roche Pharma Research and Early Development, Roche Innovation Center München, Penzberg, Germany Search for more papers by this author Peter Lundh von Leithner Peter Lundh von Leithner Department of Ocular Biology and Therapeutics, UCL London, Institute of...
Paper Details
Title
Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases
Published Date
Oct 14, 2016
Journal
Volume
8
Issue
11
Pages
1265 - 1288
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History